Skip to main content

Table 3 Viral transgenic lines for APP and Tau

From: Practical considerations for choosing a mouse model of Alzheimer’s disease

Transgene

Promoter

Viral packaging

Host

Reference

Stereotaxically Targeted APP/Aβ Viral Transgenics

 BRI-Aβ40 BRI-Aβ42

CBA

AAV1

adult rat

[137]

 huAPP695 (Swe/Lon/Aus)

(human?) EF1A

AAV (serotype not stated)

adult mouse

[138]

Stereotaxically Targeted Tau Viral Transgenics

 huMAPT 4R2N (P301L)

CAG

AAV2

adult rat

[142]

 huMAPT 4R0N (P301S)

mouse Pgk

lentivirus

adult mouse

[141]

 huMAPT 4R1N (P301L)

CMV

AAV2

adult mouse

[216]

 huMAPT 4R2N (P301L) huMAPT 4R2N (wt)

human SYN1

AAV1

adult mouse

[217]

 huMAPT 4R1N (P301L) huMAPT 4R1N (wt)

CMV

lentivirus

adult rat

[140]

 huMAPT 4R2N (P301L)

human SYN1

AAV9

adult mouse

[218]

 huMAPT 4R0N (P301S) huMAPT 4R0N (wt)

mouse Pgk1

AAV6

adult mouse

[219]

Whole-Brain Tau Viral Transgenics

 huMAPT (P301L) (isoform not stated)

CAG

AAV1

neonatal mouse

[143]

 huMAPT 4R2N (P301L)

CAG

AAV1

neonatal mouse

[220]

  1. CAG cytomegalovirus immediate early enhancer combined with the chicken β actin promoter [209]
  2. CBA chicken β-actin
  3. CMV cytomegalovirus
  4. Tables 1-4: Refer to Fig. 1 for illustration of APP mutations.